Ultragenyx Pharmaceutical, Inc. (RARE)
Q3 2018 Earnings Conference Call
November 5, 2018 17:00 ET
Executives
Danielle Keatley - IR
Emil Kakkis - President, CEO & Director
Shalini Sharp - EVP & CFO
Analysts
Gena Wang - Barclays Bank
Cory Kasimov - JPMorgan Chase & Co.
Christopher Raymond - Piper Jaffray
Maurice Raycroft - Jefferies
Liisa Bayko - JMP Securities
Vincent Chen - Sanford C. Bernstein
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Ultragenyx Third Quarter 2018 Financial Results and Corporate Update Conference Call. [Operator Instructions]. I would now like to introduce